Fosaprepitant
- Product NDC
- 16729-240
- 11-digit product format
- 167290240
- Labeler code
- 16729
- Product ID
- 16729-240_d3420392-513d-05f1-e053-2a95a90aa8a8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FOSAPREPITANT
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Accord Healthcare Inc.
- Application
- ANDA204025
- Marketing category
- ANDA
- Marketing start
- 2020-10-22
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16729-240-03 | 16729024003 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-240-03) > 5 mL in 1 VIAL, SINGLE-DOSE | 2020-10-22 | 0000-00-00 | No | No | Current |